Bioscience

Alliance for Regenerative Medicine reports significant progress on policy and membership objectives

March 31, 2010

By Flinn Foundation

[Source: PR USA] – The Alliance for Regenerative Medicine (ARM), the political voice for regenerative medicine, today reported significant progress toward its policy and membership objectives since its formation in September 2009. ARM’s achievements include an upcoming meeting with U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg, M.D., as well as a doubling of its membership to include 50 members.

For more information: Alliance for Regenerative Medicine Reports Significant Progress on Policy and Membership Objectives